JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SFE
3951
DELISTED
Safeguard Scientifics, Inc.
SFE
| $273K | ﹤0.01% |
39,116
-21,863
| -36% | -$138K |
2013 Q2
28 quarters
|
|
|
BOCH
3952
DELISTED
Bank of Commerce Holdings (CA)
BOCH
| $273K | ﹤0.01% |
36,069
-5,371
| -13% | -$39.3K |
2017 Q4
10 quarters
|
|
3953
Greenlight Captial
GLRE
$481M
| $271K | ﹤0.01% |
41,570
-367,857
| -90% | -$2.41M |
2017 Q4
10 quarters
|
|
|
THR
3954
DELISTED
Thermon Group Holdings
THR
| $271K | ﹤0.01% |
18,652
-12,970
| -41% | -$192K |
2017 Q4
10 quarters
|
|
3955
Security National Financial
SNFCA
$238M
| $270K | ﹤0.01% |
+54,864
| New | +$237K |
2020 Q2
0 quarters
|
|
3956
Tortoise North American Pipeline ETF
TPYP
$844M
| $270K | ﹤0.01% |
16,366
+1,499
| +10% | +$24.5K |
2019 Q3
3 quarters
|
|
|
ORBC
3957
DELISTED
ORBCOMM, Inc.
ORBC
| $270K | ﹤0.01% |
69,915
+45,923
| +191% | +$137K |
2017 Q3
11 quarters
|
|
3958
Alerus Financial
ALRS
$808M
| $269K | ﹤0.01% |
13,658
+8,668
| +174% | +$156K |
2019 Q4
2 quarters
|
|
3959
Brookdale Senior Living
BKD
$2.51B
| $269K | ﹤0.01% |
91,306
-272,537
| -75% | -$882K |
2013 Q2
28 quarters
|
|
3960
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.12B
| $269K | ﹤0.01% |
10,079
+9,604
| +2,022% | +$248K |
2020 Q1
1 quarter
|
|
3961
BRC Group Holdings
RILY
$196M
| $269K | ﹤0.01% |
12,375
-22,337
| -64% | -$428K |
2017 Q4
10 quarters
|
|
3962
Afya
AFYA
$1.18B
| $267K | ﹤0.01% |
+11,390
| New | +$234K |
2020 Q2
0 quarters
|
|
|
DVAX
3963
DELISTED
Dynavax Technologies
DVAX
| $267K | ﹤0.01% |
30,081
+2,734
| +10% | +$13.8K |
2016 Q3
15 quarters
|
|
3964
First Bancorp
FNLC
$386M
| $267K | ﹤0.01% |
12,317
-5,885
| -32% | -$121K |
2017 Q4
10 quarters
|
|
3965
First Bank
FRBA
$438M
| $267K | ﹤0.01% |
40,951
-21,915
| -35% | -$155K |
2018 Q2
8 quarters
|
|
3966
NRC Health Common Stock
NRC
$460M
| $267K | ﹤0.01% |
4,590
-54,563
| -92% | -$2.88M |
2017 Q4
10 quarters
|
|
3967
Stratasys
SSYS
$751M
| $267K | ﹤0.01% |
16,828
-3,636
| -18% | -$61.5K |
2015 Q3
19 quarters
|
|
3968
Global X S&P 500 Catholic Values ETF
CATH
$1.39B
| $266K | ﹤0.01% |
6,950
-8,060
| -54% | -$291K |
2020 Q1
1 quarter
|
|
3969
VanEck Emerging Markets High Yield Bond ETF
HYEM
$508M
| $266K | ﹤0.01% |
11,950
+9,461
| +380% | +$200K |
2020 Q1
1 quarter
|
|
3970
LeMaitre Vascular
LMAT
$1.85B
| $265K | ﹤0.01% |
10,031
+367
| +4% | +$9.59K |
2016 Q3
15 quarters
|
|
|
LGF.B
3971
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $265K | ﹤0.01% |
38,742
+26,675
| +221% | +$184K |
2016 Q4
14 quarters
|
|
3972
PUT
Ulta Beauty
ULTA
$23.2B
| $264K | ﹤0.01% |
1,300
-4,600
| -78% | -$989K |
2019 Q3
3 quarters
|
|
|
EBTC
3973
DELISTED
Enterprise Bancorp
EBTC
| $263K | ﹤0.01% |
11,041
-4,699
| -30% | -$109K |
2017 Q4
10 quarters
|
|
3974
VanEck Agribusiness ETF
MOO
$1.15B
| $263K | ﹤0.01% |
4,369
-266
| -6% | -$15K |
2017 Q4
10 quarters
|
|
|
FCT
3975
DELISTED
First Trust Senior Floating Rate Income Fund II
FCT
| $262K | ﹤0.01% |
24,044
-19,869
| -45% | -$210K |
2017 Q4
10 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.